article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

The global ADC market is expected to continue this steep upward trajectory and is anticipated to exceed $16 Billion by 2026. In practice, some patients may be left managing a syndrome associated with the therapy along with the disease. Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London.